Experience in Treatment of Patients Suffering from Leucosis and Solid Tumors by Fetal Stem Cells
Smikodub A.I., Snigir N.V., Radzievskaya L.V., Grinevich Y.A., Bendug G.D.
Observed were 16 patients with acute leukoses and neutropenia and 32 patients with solid tumors, among them 16 with cervical carcinoma subjected to combined radiotherapy, 13 children with osteogenic and chondroid sarcoma, and 3 children with Wilms tumor. Suspensions with high contents of stem cells of hemopoiesis were used for treatment with nucleated cells count at 50–300x106
/ml, CFU-GM at 0.6–165x103
, and CFU GEMM at 2.1–9.0x103
Upon treatment, the patients better endured cytostatic therapy. Percentage of complications reduced. Positive dynamics of infection process involving neutropenia and hemorrhagic syndrome was observed. Substantial increase in the amounts of leukocytes, thrombocytes and erythrocytes in the peripheral blood was observed on the 11th and 13th day after stem cell transplantation. Despite continuing radiotherapy, peripheral blood indices improved during the second week in cervical carcinoma patients. In patients with solid tumors, the increase in the total amount of lymphocytes, T-lymphocytes, and NK-cells was also observed. Cell therapy caused no side effects.
Fetal stem cells treatment results depend on: disease's severity, age of the patient, adherence for the medications and regime. Treatment results, presented on this site, are individual for each clinical case.